Christina Ravelo is a regulatory and compliance advisor in Ropes & Gray’s health care practice. She counsels health care companies, academic medical centers, hospitals, and higher education institutions on federal funding, enforcement risks, and a broad range of regulatory matters.
She also has extensive experience advising clients on transactional matters, including regulatory due diligence, compliance counseling, and post-closing support for private equity investments and strategic transactions.
Christina regularly guides clients through regulatory investigations—including foreign influence inquiries, False Claims Act matters, and internal compliance reviews related to federal research funding and billing practices. She collaborates with cross-disciplinary teams to manage government enforcement actions and internal investigations.
Additionally, Christina advises U.S. academic institutions on regulatory risk and cross-border compliance issues related to international gifts and contracting, including reporting required by Section 117 of the Higher Education Act and the CHIPS and Science Act of 2022.
Prior to law school, Christina was a bilingual teacher in Dallas, Texas through Teach for America, and interned at the U.S. House of Representatives. She is a native of Miami, Florida.
Experience
- Advised research universities and academic medical centers in internal investigations and responses to federal inquiries concerning foreign influence, research integrity, and Section 117 and CHIPS Act reporting compliance.
- Counseled health systems and higher education institutions on federal grant compliance and enforcement risks associated with the COVID-19 pandemic, including navigating financial relief associated with the Provider Relief Fund (PRF), FEMA, and Paycheck Protection Program (PPP) and the regulatory implications of COVID-19 testing programs.
- Represented clients in False Claims Act investigations involving research funding, coding and billing compliance, and other regulatory risks.
- Provided regulatory due diligence and post-closing compliance support for private equity investments in health care companies, including dental service organizations (DSOs), management services organizations (MSOs), and hospice and home health agencies.
- Advised on corporate practice of medicine and regulatory considerations for practice management platforms.
- Counseled academic medical centers in connection with mergers, acquisitions, and affiliations.
- Advised a pro bono substance use disorder agency client with the development and implementation of a HIPAA and 42 C.F.R Part 2 compliance program.